Study In Patients With Dyslipidaemia

PHASE2CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

June 30, 2007

Conditions
Metabolic Syndrome X
Interventions
DRUG

GW677954

Trial Locations (50)

1311

GSK Investigational Site, Auckland

1425

GSK Investigational Site, Buenos Aires

2050

GSK Investigational Site, Camperdown

3201

GSK Investigational Site, Rotorua

4021

GSK Investigational Site, Kippa-Ring

4131

GSK Investigational Site, Meadowbrook

5000

GSK Investigational Site, Córdoba

5016

GSK Investigational Site, Córdoba

5035

GSK Investigational Site, Keswick

5112

GSK Investigational Site, Elizabeth Vale

5400

GSK Investigational Site, San Juan

8014

GSK Investigational Site, Christchurch

11650

GSK Investigational Site, Mexico City

15706

GSK Investigational Site, Santiago de Compostela

18003

GSK Investigational Site, Granada

18014

GSK Investigational Site, Granada

28037

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

28935

GSK Investigational Site, Móstoles/Madrid

34000

GSK Investigational Site, Durango

42039

GSK Investigational Site, Pachuca

44340

GSK Investigational Site, Guadalajara

54000

GSK Investigational Site, Lahore

74800

GSK Investigational Site, Karachi

101990

GSK Investigational Site, Moscow

111020

GSK Investigational Site, Moscow

195067

GSK Investigational Site, S.-Petresburg

330084

GSK Investigational Site, Deva

400008

GSK Investigational Site, Mumbai

500366

GSK Investigational Site, Brasov

560034

GSK Investigational Site, Bangalore

7510605

GSK Investigational Site, Santiago

7571831

GSK Investigational Site, Santiago

Unknown

GSK Investigational Site, Buenos Aires

GSK Investigational Site, San José

380 052

GSK Investigational Site, Ahmedabad

560 054

GSK Investigational Site, Bangalore

600 116

GSK Investigational Site, Chennai

LV 1002

GSK Investigational Site, Riga

LV 1012

GSK Investigational Site, Riga

LV1005

GSK Investigational Site, Riga

LV1038

GSK Investigational Site, Riga

020045

GSK Investigational Site, Bucharest

121 552

GSK Investigational Site, Moscow

040 22

GSK Investigational Site, Košice

041 90

GSK Investigational Site, Košice

03114

GSK Investigational Site, Alicante

08022

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona

08221

GSK Investigational Site, Tarrasa, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY